Itraconazole is an antifungal prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain fungal infections, such as: Histoplasmosis. Certain types of mucocutaneouscandidiasis, including esophageal candidiasis (infection of the esophagus) and oropharyngeal candidiasis (infection of part of the throat). Histoplasmosis and mucocutaneous candidiasis can be opportunistic infections (OIs) of HIV. It is grouped under the following drug class(es): Leishmaniasis agents. Its therapeutic use is listed as anti-infectives, antifungals and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Oriconazole, Itraconazol, Sporonox and Fungitraxx. Its PubChem CID is 55283.
Itraconazole
| CAS No | 84625-61-6 |
|---|---|
| Molecular Formula | C35H38Cl2N8O4 |
| Molecular Weight | 705.6 g/mol |
| Synonyms | 2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
S. Food and Drug Administration (FDA) for the treatment of certain fungal infections, such as: Histoplasmosis. Certain types of mucocutaneouscandidiasis, including esophageal candidiasis (infection of the esophagus) and oropharyngeal candidiasis (infection of part of the throat).
The listed CAS number is 84625-61-6.
The listed molecular formula is C35H38Cl2N8O4.
The listed molecular weight is 705.6 g/mol.
2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one.
The source lists Oriconazole, Itraconazol, Sporonox and Fungitraxx.